Allarity Therapeutics, Inc. (ALLR) Adds Proteomics and Cell Line Capabilities

Allarity Therapeutics expanded its lab to include proteomics and cell line research to support stenoparib studies and external services, saying this will not affect its current cash runway.Material DetailsContext by AI AnalystThis is an incremental R&D and services expansion aligned with Allarity’s…